FIELD: pharmaceutics.
SUBSTANCE: invention relates to a pyrrolopyridine derivative of formula I or a pharmaceutically acceptable salt thereof, a pharmaceutical composition thereof and use thereof.
EFFECT: compound according to the present invention has high selectivity and bioactivity against human immunodeficiency virus (HIV), as well as low toxicity and, therefore, is applicable as a therapeutic agent against viral infection caused by human immunodeficiency virus (HIV).
4 cl, 1 tbl, 18 ex
formula I
| Title | Year | Author | Number |
|---|---|---|---|
| NOVEL PYRROLOPYRIDINE COMPOUND, METHOD FOR PRODUCTION THEREOF AND USE THEREOF | 2017 |
|
RU2733723C1 |
| HETEROCYCLIC DERIVATIVES AND USE THEREOF | 2015 |
|
RU2734390C2 |
| BENZAMIDE COMPOUNDS | 2019 |
|
RU2801647C2 |
| AZAINDOLYL PYRIDONE AND DIAZAINDOLYL PYRIDONE | 2018 |
|
RU2788659C2 |
| BICYCLIC LACTAMS AND METHODS FOR USE THEREOF | 2016 |
|
RU2716136C2 |
| HETEROBICYCLO-SUBSTITUTED-[1,2,4]TRIAZOLO[1,5-C]QUINAZOLIN-5-AMINE COMPOUNDS WITH A2A ANTAGONIST PROPERTIES | 2013 |
|
RU2671628C2 |
| CLASS OF BIFUNCTIONAL CHIMERIC HETEROCYCLIC COMPOUNDS FOR TARGETED DESTRUCTION OF ANDROGEN RECEPTORS AND USE THEREOF | 2020 |
|
RU2825000C2 |
| HETEROCYCLIC DERIVATIVES AND USE THEREOF | 2015 |
|
RU2711502C2 |
| INFLUENZA VIRUS REPLICATION INHIBITORS, METHODS OF APPLICATION AND USING | 2016 |
|
RU2737190C2 |
| NEW PYRAZOLE-3-CARBOXAMIDE DERIVATIVE POSSESSING ANTAGONIST ACTIVITY ON 5-НТ RECEPTOR | 2009 |
|
RU2528406C2 |
